Where to buy CJC-1295 in the UK: the sellers with a verifiable COA
The newest verifiable CJC-1295 certificate on any UK seller's website is on Lab77Peptides (lab77peptides.uk), analysed 29 Sep 2026 (task #231387 on Janoshik's site); 6 verified sellers hold one covering CJC-1295, listed newest first below.
A record of paperwork, not a recommendation: The Peptide Watch sells nothing, takes no money from sellers and links to none of them.
Who has the newest report · Why the date matters · What purity means · What CJC-1295 is · Regulators · Every report
Who holds the newest CJC-1295 report (6 verified UK sellers)
Newest report first. Every report was opened on Janoshik's own website and names the seller as the client. The date is the analysis date printed on the report. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Newest CJC-1295 report | Age of that report | Purity on it | |
|---|---|---|---|---|
| Lab77Peptides | 29 Sep 2026 | 11 days | 99.239% | verify |
| Imperialpeptides | 13 May 2026 | 4 months, 27 days | 99.696% | verify |
| Thoroughbredlabs | 12 May 2026 | 4 months, 28 days | 99.322% | verify |
| Kensingtonlabs | 5 May 2026 | 5 months, 5 days | 99.625% | verify |
| Xlpeptides | 9 Apr 2026 | 6 months, 1 day | 99.733% | verify |
| Clinicore | 23 Jan 2026 | 8 months, 17 days | 99.753% | verify |
Every CJC-1295 purity report we have read (7), one row per report
The 7 verifiable CJC-1295 certificates we have read, newest first
Each row was opened on Janoshik's own site by a real page load and transcribed. The client column is the name the laboratory printed; a certificate counts as a seller's own only when that name is the seller. The report date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Task | Client on the report | Report date | Result | Batch | |
|---|---|---|---|---|---|---|
| Lab77Peptides | #231387 | Lab77peptides.uk | 29 Sep 2026 | CJC-1295 (mod GRF 1-29) · 9.92 mg · 99.239% | L77CJCND2612 | verify |
| Imperialpeptides | #154278 | Imperial Peptides UK | www.imperialpeptides.co.uk | 13 May 2026 | CJC-1295 (mod GRF 1-29) · 5.36 mg · 99.696% | CND5-04/28 | verify |
| Thoroughbredlabs | #155576 | Thoroughbred Labs | [email protected] | 12 May 2026 | CJC-1295 (mod GRF 1-29) · 5.33 mg · 99.322% | TBLCJ801 | verify |
| Kensingtonlabs | #121930 | Kensington Labs | 5 May 2026 | CJC-1295 (mod GRF 1-29) · 5.15 mg · 99.625% | CND-695SJ | verify |
| Xlpeptides | #134931 | XL Peptides | 9 Apr 2026 | CJC-1295 (mod GRF 1-29) · 4.91 mg · 99.733% | 302CJC | verify |
| Clinicore | #101986 | clinicore | 23 Jan 2026 | CJC-1295 (mod GRF 1-29) · 12.85 mg · 99.753% | cjcnd10101 | verify |
| Imperialpeptides | #92878 | Imperial Peptides UK | www.imperialpeptides.co.uk | 10 Dec 2025 | CJC-1295 DAC · 5.48 mg · 99.401% | CWD5-10/27 | verify |
Why the date on a certificate matters
What a purity figure means
The purity on a Janoshik report is the share of the main peak in an HPLC chromatogram. 99.5% means that 99.5% of what the detector saw was one substance and 0.5% was something else. It is not the amount in the vial: that is the separate quantity line, in milligrams. It does not by itself prove which substance the peak is: that is identity, confirmed by mass spectrometry. And it says nothing about sterility, endotoxins or heavy metals, which are separate tests.
A purity figure printed on a shop page with no report behind it is a claim, not a measurement. Between two reports, the difference that matters is rarely 99.2% against 99.8%; it is whether the report exists at all, names the seller as the client, covers this compound on its own, and is recent.
What CJC-1295 is, and what it is sold as
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH) used in laboratory research, and is commonly paired with ipamorelin. Check whether a seller's certificate covers CJC-1295 specifically, or only one compound in a blend.
| Development status | Development abandoned. ConjuChem halted its phase 2 trial in July 2006 after a participant death and never resumed; never approved anywhere. |
|---|---|
| Originator | ConjuChem (Canada), 2000s. Rights: No active developer since ConjuChem halted the programme in 2006. |
| Registered clinical trials | 1 on ClinicalTrials.gov |
A long-acting growth-hormone-releasing analogue whose trial ended with a death. ConjuChem developed CJC-1295 in the 2000s. PubMed indexes 33 papers and 2 clinical-trial reports; ClinicalTrials.gov lists a single registered trial, ConjuChem's phase 2 in HIV-related visceral fat (NCT00267527).
Development stopped in July 2006 after a participant at an Argentine site died; the attending physician judged the likely cause to be undiagnosed coronary disease and unrelated to the drug, and ConjuChem halted the programme as a precaution. It never resumed.
Nothing sold as CJC-1295 today has a developer, a licence or a human safety record beyond that trial. The certificate is the only checkable fact about a vial.
The published record in numbers, and the sources
| Papers on PubMed | 33 |
|---|---|
| Indexed as rat or mouse studies | 3 |
| Indexed as clinical trials | 2 |
| Published since 2020 | 17 |
Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file. A description of the published record, not medical advice and not an argument for or against use.
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. (J Clin Endocrinol Metab, 2006, PMID 17018654)
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. (J Clin Endocrinol Metab, 2006, PMID 16352683)
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. (Am J Sports Med, 2026, PMID 41476424)
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (J Am Acad Orthop Surg Glob Res Rev, 2026, PMID 41490200)
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. (Sports Med, 2026, PMID 41966639)
- aidsmap, July 2006, lipodystrophy study halted after patient death
- ClinicalTrials.gov NCT00267527
What regulators say about CJC-1295
In the UK. Not a licensed medicine in the UK. Sold as a research chemical.
We hold no statement from the FDA, MHRA or EMA specifically about CJC-1295 on file. Its development and licence sources are listed under the record above.
What the 7 CJC-1295 certificates show
We have read 7 Janoshik reports covering CJC-1295, published by 6 UK sellers. Each was opened on Janoshik's own website. All 7 name the seller itself as the client. 4 of the 7 are dated within the last six months. The newest is dated 29 Sep 2026 and the oldest 10 Dec 2025.
All 7 reports give a purity figure for CJC-1295. The figures run from 99.239% to 99.753%, and all 7 are at 99% or above. A purity figure describes the sample the laboratory received, not every vial from that batch.
Read directly from the newest reports: Lab77Peptides: task #231387, analysed 29 Sep 2026, 9.92 mg recovered at 99.239%, client Lab77peptides.uk; Imperialpeptides: task #154278, sample received 13 May 2026, 5.36 mg recovered at 99.696%, client Imperial Peptides UK; Thoroughbredlabs: task #155576, sample received 12 May 2026, 5.33 mg recovered at 99.322%, client Thoroughbred Labs.
A certificate is a batch document. The lines that matter are the compound (it must say CJC-1295, not only a batch code), the client (the shop, not its supplier) and the analysis date. A new batch is untested until a new report appears.
CJC-1295 in the UK at a glance
| Active UK sellers listing CJC-1295 | 37 |
|---|---|
| Of which publish a verifiable own-name certificate | 9 |
| Of which name no laboratory at all | 7 |
Counted from the vendor ledger at build time. The A-Z directory lists every seller and what each publishes instead.
Questions people ask
Which UK sellers publish a verifiable Janoshik certificate naming CJC-1295?
As of 10 October 2026, 6: Lab77Peptides, Imperialpeptides, Thoroughbredlabs, Kensingtonlabs, Xlpeptides, Clinicore. Each has a report on Janoshik's own website that names the seller as the client and lists CJC-1295. That is a statement about paperwork, not a recommendation; The Peptide Watch does not recommend anywhere to buy CJC-1295.
How recent is the newest CJC-1295 certificate from a UK seller?
The newest we have read is Janoshik task #231387, analysed 29 Sep 2026. It is published by Lab77Peptides and names it as the client. A certificate covers one batch, so an old one says little about stock on sale today.
How do I check that a certificate for CJC-1295 is genuine?
Four things: an independent laboratory is named; the client field names the seller you are buying from, not a supplier; the compound line says CJC-1295; and the report's task number and key open the same report on the laboratory's own website (verify.janoshik.com). A branded PDF with no laboratory name and no verification code fails on the first check, however professional it looks. The free COA Checker on this site runs the checks for you.
Is CJC-1295 a licensed medicine in the UK?
Not a licensed medicine in the UK. Sold as a research chemical. ConjuChem halted its phase 2 trial in July 2006 after a participant death and never resumed; never approved anywhere. The Peptide Watch does not give legal or medical advice.
Why does The Peptide Watch not say where to buy CJC-1295?
Because the site records paperwork, not recommendations. A verifiable certificate proves that a sample of one batch was tested. It does not prove the vial you receive matches it, and it says nothing about whether anyone should use CJC-1295. Listing which sellers publish a certificate you can check, and which publish nothing, is as far as the evidence goes.
The Peptide Watch's position on CJC-1295
Not a licensed medicine in the UK. Sold as a research chemical. The Peptide Watch reads the certificates UK sellers publish and does not recommend anywhere to buy CJC-1295. Sellers on this page are listed by the date of their newest CJC-1295 certificate and by nothing else. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are taking the seller's word for what is in the vial. See how UK testing compares across every seller in the market statistics.
An honest note: a verifiable certificate proves a sample of a batch was tested, not that the specific vial you receive matches it, see what this can and can't tell you. The Peptide Watch sells no CJC-1295 and links to no shop; this is research-use-only information, not medical or dosing advice.
All peptides · Other compounds: BPC-157 · TB-500 · GHK-Cu · Ipamorelin · MOTS-c · Epithalon · Selank · Semax · Tesamorelin · Melanotan 2 · KPV · PT-141 · SS-31 · DSIP · NAD+ · Melanotan 1 · AOD-9604 · 5-Amino-1MQ · Glutathione · Kisspeptin · Thymosin Alpha-1 · GHRP-6 · HGH Fragment 176-191 · IGF-1 LR3 · FOXO4-DRI · Oxytocin · SLU-PP-332 · MK-677 · GLOW and KLOW blends · Sermorelin · GHRP-2 · Hexarelin · ARA-290 · AHK-Cu